Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 47(6): 478-482, 06/2014. graf
Article Dans Anglais | LILACS | ID: lil-709446

Résumé

Accumulating evidence has indicated the importance of cancer stem cells in carcinogenesis. The goal of the present study was to determine the effect of low-dose cisplatin on enriched liver cancer stem cells (LCSCs). Human hepatoblastoma HepG2 cells were treated with concentrations of cisplatin ranging from 1 to 5 μg/mL. Cell survival and proliferation were evaluated using a tetrazolium dye (MTT) assay. LCSCs were identified using specific markers, namely aldehyde dehydrogenase-1 (ALDH1) and CD133. The percentage of ALDH1+ or CD133+ cells was examined by flow cytometric analysis. The expression of ALDH1 and/or CD133 in HepG2 cells was determined by immunocytochemical analysis. Low-dose cisplatin treatment significantly decreased cell survival in HepG2 cells after 24 or 72 h. However, the percentage of LCSCs in the surviving cells was greatly increased. The percentage of ALDH1+ or CD133+ cells was increased in a time- and dose-dependent manner after treatment with 1-4 μg/mL cisplatin, whereas 5 μg/mL cisplatin exposure slightly reduced the number of positive cells. These findings indicate that low-dose cisplatin treatment may efficiently enrich the LCSC population in HepG2 cells.


Sujets)
Humains , Antinéoplasiques/administration et posologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Cisplatine/administration et posologie , Hépatoblastome/traitement médicamenteux , Tumeurs du foie/traitement médicamenteux , Cellules souches tumorales/effets des médicaments et des substances chimiques , Antigènes CD/analyse , Lignée cellulaire tumorale , Carcinogenèse/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Cisplatine/usage thérapeutique , Cytométrie en flux , Glycoprotéines/analyse , Hépatoblastome/anatomopathologie , Immunohistochimie , Isoenzymes/analyse , Tumeurs du foie/anatomopathologie , Cellules souches tumorales/cytologie , Peptides/analyse , Retinal dehydrogenase/analyse , Sels de tétrazolium , Marqueurs biologiques tumoraux/analyse
SÉLECTION CITATIONS
Détails de la recherche